RILYK Q1 2024 Earnings Negative EPS Reported as Bond Price Edges Higher PureTech Health Q4 2024 Earnings EPS Misses Estimates as ClinicalStage Biotech Reports Results LVS Q1 2026 Earnings Strong EPS Beat Amid Macau Recovery RILYP Q1 2024 Earnings Negative EPS Amid Preferred Stock Challenges IMMR Q3 2025 Earnings EPS Beat Drives Positive Market Reaction Licensing Revenue Remains Opaque Robin Energy Ltd RBNE Declines 348 as Stock Approaches Critical Support Zone Calavo Growers CVGW Rebounds Key Levels and Potential Catalysts TherapeuticsMD TXMD Edges Higher as Support Holds Near 201 Centene CNC Declines 326 as Shares Approach Critical Support XOM Q1 2026 Earnings Solid EPS Beat of 143 Despite Flat Revenue Environment